Blood Group Typing Market Share

  • Report ID: 4555
  • Published Date: Apr 18, 2025
  • Report Format: PDF, PPT

Blood Group Typing Industry - Regional Synopsis

North American Market Forecast   

The North American blood group typing market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037 backed by the increasing need for platelets and blood transfusion components. For instance, nearly 5,000 units of platelets and 6.500 units of plasma are needed daily in the U.S. and Nearly 16 million blood components are transfused each year in the U.S. Furthermore, availability of favorable reimbursement policies, rising cases of chronic diseases many of which require blood type determination for effective treatment, and high prevalence of infectious diseases are expected to drive blood group typing market growth in the region during the forecast period.

APAC Market Statistics

On the other hand, the market in the Asia Pacific region is also estimated to hold a significant market share. The massive investments in developing advanced blood group typing technologies along with the presence of a large pool of patients waiting for blood transfusion diagnostics are the major factors for the market growth during the forecast period. Rising healthcare expenditure and improved hospital settings for blood donations also anticipated to bring lucrative growth opportunities for the market.

Blood Group Typing Market share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

2025 Blood Group Typing Market is estimated at USD 1.22 billion.

The global blood group typing market size exceeded USD 1.15 billion in 2024 and is projected to expand at a CAGR of more than 7.1%, crossing USD 2.81 billion by 2037.

North America is anticipated to capture a dominant industry share, attributed to the increasing need for platelets and blood transfusion components, as well as favorable reimbursement policies and high prevalence of chronic diseases.

The major players in the market include Seegene Inc, .QuidelOrtho Corporation, Rapid Labs Ltd, BAG Health Care GmbH, Quotient Suisse SA, Bio-Rad Laboratories Inc., Beckman Coulter Inc., Grifols, S.A., Immucor Inc., Novacyt Group.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos